Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Shares Outstanding (Weighted Average) (2016 - 2025)

Anaptysbio (ANAB) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $28.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 1.32% year-over-year to $28.8 million, compared with a TTM value of $28.8 million through Dec 2025, up 1.32%, and an annual FY2025 reading of $28.8 million, up 1.32% over the prior year.
  • Shares Outstanding (Weighted Average) was $28.8 million for Q4 2025 at Anaptysbio, up from $27.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $30.6 million in Q1 2025 and bottomed at $26.8 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $27.9 million, with a median of $27.8 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) dropped 4.42% in 2023, then rose 14.34% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $27.4 million in 2021, then grew by 2.68% to $28.2 million in 2022, then fell by 4.41% to $26.9 million in 2023, then grew by 5.42% to $28.4 million in 2024, then increased by 1.32% to $28.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ANAB at $28.8 million in Q4 2025, $27.8 million in Q3 2025, and $28.8 million in Q2 2025.